Quantification of the hypothalamic proline rich polypeptide-1 in rat blood serum

Pleiades Publishing Ltd - Tập 8 - Trang 38-43 - 2014
S. S. Abrahamyan1,2, T. K. Davtyan3, A. R. Khachatryan1, N. V. Tumasyan1, I. K. Sahakyan1, H. A. Harutyunyan1, S. G. Chailyan1, A. A. Galoyan1
1Institute of Biochemistry after Buniatian, NAS RA, Yerevan, Armenia
2Yerevan, Armenia
3Laboratory of Immunology and Virology, Armenicum Research Center, Yerevan, Armenia

Tóm tắt

Proline rich polypeptide-1 (PRP-1) consisting of 15 amino acid residues (AGAPEPAEPAQPGVY) is a regulatory hypothalamic peptide possessing neuroprotective, immunoregulatory, hematopoietic, and antimicrobial properties. In order to quantify PRP-1 in rat blood, an enzyme linked immunosorbent assay (ELISA) has been applied using polyclonal antibody raised against the synthetic PRP-1 named “Galarmin”. In the present study, two post-injection periods were tested (5 hours and 2 days) after intraperitoneal (i/p) administration of PRP-1. The minimum detectable concentration of PRP-1 in intact rat blood serum has been shown to be approximately 1.78 ng/mL. A significant increase of PRP-1 concentration in the blood samples has been observed in 5 hours after the PRP-1 i/p injection; however the peptide amount in the blood has been decreasing in 2 day post-injection period, approximating to the control level, which could be caused by the peptide proteolitic breakdown.

Tài liệu tham khảo

Galoyan, A.A., Proc. NAS RA, 1996, pp. 555–570. Galoyan, A.A., Biochemistry of Novel Cardioactive Hormones and Immunomodulators of the Functional System Neurosecretory Hypothalamus-Endocrine Heart, Moscow, 1997. Galoyan, A.A., Neurochem. Res., 2001, vol. 25, pp. 1343–1355. Galoyan, A.A., Terio, T., Berg, M., and Marks, N., Neirokhimiya (RAS and NAS RA), 2000, vol. 17, pp. 185–188. Galoyan, A.A. and Aprikyan, V.S., Neurochem. Res., 2002, vol. 27, pp. 305–312. Aprikian, V.S., Galoyan, K.A., and Galoyan, A.A., J. Neurochem., 1999, vol. 72, p. S68D. Galoyan, A.A., Aprikyan, V.S., Markossian, K.A., and Gurvits, B.Ya., H Neirokhimiya (RAS and NAS RA), 1998, vol. 15, pp. 361–372. Davtyan, T.K., Manukyan, N.A., Mkrtchyan, R., and Galoyan, A.A., Neurochem. Res., 2005, vol. 3, pp. 297–309. Galoyan, A.A., Kipriyan, T.K., Sarkissian, J.S., Sarkissian, E.J., Grigorian, Y.Kh., Andreasian, A.S., and Chavushyan, E.A., Neurochem. Res., 2000, vol. 25, pp. 791–800. Aprikyan, V.S. and Galoyan, A.A., Med. Sci. Armenia, 1999, vol. 31, no. 4, pp. 29–36. Aprikian, V.S. and Galoyan, A.A., Neurokhimiya (RAS and NAS RA), 2000, vol. 17, pp. 60–63. Chekhonin, V., Gurina, O., Ruabukin, I., Savchenko, E., and Galoyan A.L., Proceedings of the International Conference on Biochemical and Molecular-Biological Aspects of the Brain Immune System, 2001, pp. 140–145. Galoyan, A.A., Sarkissian, J.S., Kipriyan, T.K., Sarkissian, E.J., Chavushyan, E.A., Sulkhanyan, R.M., Meliksetyan, I.B., Abrahamyan, S.S., Grigorian, Y.Kh., Avetisyan, Z.A., and Otieva, N.V., Neurochem. Res., 2001, vol. 26, pp. 1023–1038. Galoyan, A.A., Proceedings of the International Conference on Biochemical and Molecular-Biological Aspects of the Brain Immune System, 2001, pp. 22–34. Galoyan, A.A., Sarkissian, J.S., Kipriyan, T.K., Sarkissian, E.J., Grigorian, Y.Kh., Sulkhanyan, R.M., and Khachatryan, T.S., Neurochem. Res., 2000, vol. 25, pp. 1567–1578. Abrahamyan, S.S., Sarkissian, J.S., Meliksetyan, L.B., and Galoyan, A.A., Neurochem. Res., 2004, vol. 29, pp. 695–708. Abrahamyan, S.S., Meliksetyan, I.B., Chavushyan, V.A., Aloyan, M.L., and Sarkissian, I.S., Clin. Neurosci., 2007, vol. 60, nos. 3–4, pp. 148–153. Galoyan, A.A., Sarkissian, J.S., Chavushyan, E.A., Abrahamyan, S.S., Grigorian, Y.Kh., Neurokhimiya, 2004, vol. 21, no. 4, pp. 265–288. Shakhlamov, V.A., Galoyan, A.A., Polyakova, G.N., Vagradyan, A.G., Simonyan, M.A., Agadzhanov, M.I., Bogdanova, I.M., Altukhova, V.I., and Kondakova, L.I., Dokl. NAN AR, 2002, vol. 102, pp. 166–172. Kirakosova, A.S., Abrahamyan, S.S., Tumasyan, N.V., Davtyan, T.K., and Khachatryan, A.R., Neurochem. Res., 2012, vol. 37, no. 1, pp. 2–4. Abrahamyan, S.S., Meliksetyan, I.B., Sulkhanyan, R.M., Sarkissian, J.S., and Galoyan, A.A., Neurochem. Res., 2001, vol. 26, pp. 1225–1230. Mentlein, R., FEBS Lett., 1998, vol. 234, pp. 251–256. Yaron, A. and Naider, F.H., Crit. Rev. Biochem. Mol. Biol., 1993, vol. 28, pp. 31–81. Brandt, I., Lambeir, A.M., and Maes, M.B., Adv. Exp. Med. Biol., 2006, vol. 575, pp. 3–18. Mentlein, R., Regular Pept., 1999, vol. 85, pp. 9–24. Lambeir, A.M., Durinx, Ch., Proost, P., Van Damme, J., Scharpe, S., and De Meester, I., FEBS Lett., 2001, vol. 507, pp. 327–330. Antonyan, A.A., Sharoyan, S.G., Mardanyan, S.S., and Galoyan, A.A., Neurochem. Res., 2011, vol. 36, no. 1, pp. 34–38. Ambrosius, X., Immunol. Methods, Frimel, G., Ed., 1987, pp. 14–15. Bret-Dibat, J.L., Zouaoui, D., Dery, O., Zerari, F., Grassi, J., Maillet, S., Conrath, M., and Couraud, J.Y., J. Neurochem., 2004, vol. 63, pp. 333–343. Reinhold, D., Kähne, T., and Steinbrecher, A., Signal Transduction, 2005, vol. 5, pp. 258–265. Abrahamyan, S.S., Sahakyan, I.K., Meliksetyan, I.B., Tumasyan, N.V., Badalyan, B.Yu., and Galoyan, A.A., New Armen. Med. J., 2011, vol. 5, no. 2, pp. 60–68. Tumasyan, N.V., Abrahamyan, S.S., Sahakyan, I.K., Meliksetyan, I.B., Badalyan, B.Yu., and Galoyan, A.A., Proceedings of the Keystone Symposia, 2013, p. 93. Danielyan, M.A., Sahakyan, I.K., Tumasyan, N.V., Abrahamyan, S.S., Meliksetyan, I.B., Proceedings of Second International Scientific Conference of Gorisskii State University, 2001, pp. 146–151.